Lord, Abbett & Co. LLC Medpace Holdings, Inc. Transaction History

Lord, Abbett & Co. LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	SELL	$227.52 - $312.68 $24.5 Million - $33.7 Million	-107,745 Reduced 94.03%	6,843 $2.1 Million
Q4 2023 Feb 12, 2024	SELL	$227.52 - $312.68 $24.5 Million - $33.7 Million	-107,745 Reduced 94.03%	6,843 $2.1 Million
Q3 2023 Oct 07, 2024	BUY	$233.98 - $281.67 $23.4 Million - $28.2 Million	99,949 Added 682.76%	114,588 $27.7 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $23.4 Million - $28.2 Million	99,949 Added 682.76%	114,588 $27.7 Million
Q2 2023 Oct 07, 2024	SELL	$187.26 - $240.17 $17.7 Million - $22.7 Million	-94,361 Reduced 86.57%	14,639 $3.52 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $2.74 Million - $3.52 Million	14,639 New	14,639 $3.52 Million
Q4 2022 Oct 07, 2024	BUY	$153.06 - $226.57 $16.7 Million - $24.7 Million	109,000 New	109,000 $23.2 Million
Q4 2022 Feb 10, 2023	BUY	$153.06 - $226.57 $16.7 Million - $24.7 Million	109,000 New	109,000 $23.2 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.